Bausch Health Companies Investor Conference Presentation Deck
Bausch + Lomb At-A-Glance
Key Leadership Appointments
8
Joe Papa
Chief Executive Officer
Sam Eldessouky
Chief Financial Officer
Christina Ackermann
General Counsel & Head
Ophthalmology Rx U.S.,
Canada, Latin America
and Asia Pacific
Joe Gordon
Head, Global Consumer,
Vision Care, Surgical and
EMEA Ophthalmology Rx
BAUSCH- Health
Bausch + Lomb Revenue Portfolio ¹
1. YTD Revenue as of 9/30/21.
Global
Ophtho Rx,
19%
LUMIFY
REDNESS RELIEVER EYE DROPS
Global
Consumer,
38%
BAUSCH+LOMB
B+L
BAUSCH+LOMB
BAUSCH+LOMB
ULTRA
Global Vision
Care, 24%
Global
Surgical, 19%
BAUSCH + LOMB
Ocuvite
Eye Vitamin & Mineral Supplement
✓
VYZULTA
a
enVista IOL
Post Separation Profile
Expected Tax Rate: A few
hundred basis points higher
than Bausch Pharma
Domiciled: Canada; U.S.
corporate offices will be in
Bridgewater, NJ
Intend to apply for lis
NYSE and TSX
Stellaris
BAUSCH + LOMB
PreserVision™
EYE VITAMIN AND
MINERAL SUPPLEMENT
AUSCHLOW
AUSLOM
BAUSER LOWE
Bio
true
on:
INFUSEView entire presentation